Given Imaging CEO Homi Shamir said that the win strengthens the company's competitive position in Germany.
Pillcam developer Given Imaging Ltd. (Nasdaq: GIVN; TASE: GIVN) continues its recent string of good news from Germany.
Given said that the Regional Court (Patent Chamber) in Düsseldorf, Germany has ruled that the MiroCam capsule endoscopy system manufactured by IntroMedic of South Korea infringes two patents asserted by Given Imaging.
The court's rulings allow Given Imaging to prevent IntroMedic's German distributor, Medwork Medicinal Products and Services GmbH from selling the current model of the MiroCam capsule and MiroView software in Germany.
Given Imaging CEO Homi Shamir said that the win strengthens the company's competitive position in Germany.
Given Imaging shares closed at $18.48 on Friday, giving a market cap of $551.24 million.
Published by Globes [online], Israel business news - www.globes-online.com - on March 21, 2011
© Copyright of Globes Publisher Itonut (1983) Ltd. 2011